Losman; Michele J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Losman; Michele J..The latest application filed is for "methods of treating cancer with antibodies that target the insulin-like growth factor type i receptor (igf-1r)".

Company Profile

1.6.8

Losman; Michele J. - South Orange NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isolated nucleic acid encoding an anti-IGF-1R antibody Grant 10,377,829 - Chang , et al. A	2019-08-13
Methods Of Treating Cancer With Antibodies That Target The Insulin-like Growth Factor Type I Receptor (igf-1r) App 20170320952 - Chang; Chien-Hsing ; et al.	2017-11-09
Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R) Grant 9,751,948 - Chang , et al. September 5, 2	2017-09-05
Methods Of Treating Cancer With Antibodies That Target The Insulin-like Growth Factor Type I Receptor (igf-1r) App 20160333098 - Chang; Chien-Hsing ; et al.	2016-11-17
Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R) Grant 9,441,043 - Chang , et al. September 13, 2	2016-09-13
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) App 20150183880 - Chang; Chien-Hsing ; et al.	2015-07-02
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) App 20140086830 - Chang; Chien-Hsing ; et al.	2014-03-27
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) App 20100226884 - Chang; Chien-Hsing ; et al.	2010-09-09
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications Grant 7,413,736 - Leung , et al. August 19, 2	2008-08-19
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications Grant 7,348,419 - Leung , et al. March 25, 2	2008-03-25
Humanization Of An Anti-carcinoembryonic Antigen Anti-idiotype Antibody As A Tumor Vaccine And For Targeting Applications App 20080069775 - Leung; Shui-on ; et al.	2008-03-20
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications App 20050048053 - Leung, Shui-on ; et al.	2005-03-03
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications Grant 6,730,300 - Leung , et al. May 4, 2	2004-05-04
Humanization Of An Anti-carcinoembryonic Antigen Anti-idiotype Antibody And Use As A Tumor Vaccine And For Targeting Applications App 20030054003 - LEUNG, SHUI-ON ; et al.	2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.